VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
95 hedge funds and large institutions have $317M invested in Viracta Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% more funds holding
Funds holding: 73 → 95 (+22)
Holders
95
Holding in Top 10
–
Calls
$9.11M
Puts
$3.94M
Top Buyers
| 1 | +$22.1M | |
| 2 | +$12.3M | |
| 3 | +$9.12M | |
| 4 |
O
OrbiMed
New York
|
+$7.93M |
| 5 |
HM
HealthCor Management
New York
|
+$4.56M |
Top Sellers
| 1 | -$6.79M | |
| 2 | -$4.09M | |
| 3 | -$2.45M | |
| 4 |
DCM
Decade Capital Management
New York
|
-$2.17M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.86M |